Kodiak Sciences (KOD) Free Cash Flow (2017 - 2026)
Kodiak Sciences (KOD) reported Free Cash Flow of -$41.0 million for Q1 2026, down 39.54% on a YoY basis from -$67.7 million in Q1 2025, and down 3.88% quarter-over-quarter from -$39.4 million in Q4 2025.
Kodiak Sciences (KOD) Free Cash Flow (2017 - 2026) Analysis & Trends
Kodiak Sciences has reported Free Cash Flow for 10 years, with the latest figure at -$41.0 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 39.54% year-over-year to -$41.0 million; the trailing twelve-month figure through Mar 2026 stood at -$148.1 million (down 37.91% YoY), and the FY2025 full-year result was -$136.5 million, down 16.01% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$41.0 million, down from -$39.4 million in the prior quarter.
- The five-year high for Free Cash Flow was -$21.3 million in Q3 2024, with the low at -$63.4 million in Q2 2022.
- Historically, Free Cash Flow has averaged -$43.2 million across 5 years, with a median of -$39.6 million in 2024.
- Annual changes were most pronounced in 2022 — Free Cash Flow slumped 69.04% — and 2024, when it jumped 49.48%.
- Kodiak Sciences' Free Cash Flow stood at -$58.2 million in 2022, then dropped by 2.65% to -$59.7 million in 2023, then jumped by 49.48% to -$30.2 million in 2024, then plunged by 30.64% to -$39.4 million in 2025, then retreated by 3.88% to -$41.0 million in 2026.
- The last three Free Cash Flow figures came in at -$41.0 million (Q1 2026), -$39.4 million (Q4 2025), and -$32.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 63,220.27 |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | -40.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.95 Mn |
| Mar 31, 2026 | -40.95 Mn |
| Dec 31, 2025 | -39.42 Mn |
| Dec 31, 2025 | -39.42 Mn |
| Sep 30, 2025 | -32.89 Mn |
| Sep 30, 2025 | -32.89 Mn |
| Jun 30, 2025 | -34.86 Mn |
| Jun 30, 2025 | -34.86 Mn |
| Mar 31, 2025 | -29.35 Mn |
| Mar 31, 2025 | -29.35 Mn |
| Dec 31, 2024 | -30.18 Mn |
| Dec 31, 2024 | -30.18 Mn |
| Sep 30, 2024 | -21.33 Mn |
| Sep 30, 2024 | -21.33 Mn |
| Jun 30, 2024 | -26.55 Mn |
| Jun 30, 2024 | -26.55 Mn |
| Mar 31, 2024 | -39.62 Mn |
| Mar 31, 2024 | -39.62 Mn |
| Dec 31, 2023 | -59.72 Mn |
| Dec 31, 2023 | -59.72 Mn |